Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study-Reference-Cited by-同舟云学术

Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study

Published:2011-02-08 Issue:1 Volume:9 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Chintamani ,Tandon Megha,Mishra Ashwani,Agarwal Usha,Saxena Sunita

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/1477-7819-9-19.pdf

Reference26 articles.

1. Cure H, Amat S, Penault-Llorca F, le Bouëdec G, Ferrière JP, Mouret-Reynier MA, Kwiatkowski F, Feillel V, Dauplat J, Chollet P: Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy. Breast Cancer res Treat. 2002, 76: 37-45. 10.1023/A:1020274709327.

2. Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE: Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease free survival in patients with locally advanced breast cancer. Am J Surg. 1998, 176: 502-9. 10.1016/S0002-9610(98)00253-0.

3. Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, Vielh P, Bourstyn E: Incidence and prognostic signioficance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 2002, 20: 1304-10. 10.1200/JCO.20.5.1304.

4. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB, Hoehn JL, Lees AW, Dimitrov NV, Bear HD: Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998, 16: 2672-2685.

5. Van der Hage JA, Van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L, van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L: Preoperative chemotherapy in primary operable breast cancer: results from the European Organisation for Research and Treatment of Cancer trial 10902. J Clin Oncol. 2002, 19: 4224-37.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Axilla With Sentinel Lymph Node Biopsy (Using Methylene-Blue) and Reverse Axillary Mapping (Using Fluorescein) to Validate Optimum and Safe Axillary Dissection in Breast Cancer;Cureus;2023-09-14

2. The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review;Clinical and Translational Oncology;2022-09-25

3. Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data;Annals of Surgical Oncology;2022-01-11

4. Butea Monosperma Shows Anti-cancer and Anti-Oxidant Activity: In-vitro and In vivo Study;Journal of Pharmaceutical Research International;2021-10-18

5. Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients;The Breast;2021-10